News

EARLY TAVR update: New data highlight continued benefits of treating asymptomatic aortic stenosis

Philippe Généreux, MD, presented updated findings from one of cardiology's most closely watched trials at New York Valves 2026.

AI-powered brain tumor segmentation tool earns clearance in US

The clearance marks a key milestone in the company’s expansion into the North American market.

Clinicians are making more money despite stagnant reimbursement. Guess how?

Compensation for healthcare providers rose some 4.3% in 2025. The sobering news is that the gain owes more to heavier daily workloads than to bigger per-patient billings.

Kentucky doc earns $3.5M judgment after seven-year court battle over complaint he was ‘on something’

The state’s Supreme Court restored the judgment, agreeing that John Farmer, Jr., MD, was branded with a “proverbial scarlet letter” after the complaint, which spiraled out of control and damaged his career.

Data breach on healthcare AI vendor exposes records from 1.4M patients

A phishing attack on Xsolis, a Tennessee-based company whose list of clients includes hospitals and healthcare payers, was confirmed to have exposed sensitive medical information, including details on treatments that patients received.

Neuroimaging utilization in emergency departments has increased year-over-year for a decade

Researchers believe their new data could be used to better inform staffing coverage in modern radiology departments.

Radiology gets 68 new FDA-cleared algorithms

Radiology makes up more than 76% of all of the FDA-cleared clinical AI algorithms.

FDA recall medical device recall product recall

Thousands of heart surgery kits recalled due to FDA quality concerns

Specific lots of several procedure kits have been recalled after the FDA identified quality issues during a recent inspection.

The Medtronic CoreValve Evolut and the Edwards Lifesciences Sapien 3 TAVR valves.

TAVR still a safe option for patients with nickel allergies

More research is still needed, as this study only included data from a small number of patients, but TAVR was not linked to any severe adverse events or allergic reactions.

warning safety alert recall healthcare issue

FDA issues recall of intraoperative imaging system due to safety risks

The system enables surgeons to intraoperatively illuminate cancerous tissue in the breast cavity during lumpectomy surgery.

Joshua M. Hare, MD, FACC, FAHA, a professor of medicine, molecular and cellular pharmacology, and biomedical engineering, director of regenerative medicine, and director of the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami, and co-founder and chief science officer for the stem cell start-up Longeveron, explains the FDA trial for laromestrocel (Lomecel-B) to treat hypoplastic left heart syndrome (HLHS).

First study of its kind to focus on new therapy for hypoplastic left heart syndrome

The new trial represents a potential breakthrough in the treatment of one of the most devastating congenital heart defects.

Why patient selection is so important when performing M-TEER

As mitral transcatheter edge-to-edge repair continues to gain momentum in the United States, a new study of CMS data examines what happens to patient outcomes when the procedure fails.

Around the web

Cardiovascular Business